{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:04:16Z","timestamp":1774688656228,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.intimp.2026.116566","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:17:01Z","timestamp":1774358221000},"page":"116566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential"],"prefix":"10.1016","volume":"177","author":[{"given":"Gui-Rong","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116566_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/1751-2980.13294","article-title":"Chinese consensus on the management of liver cirrhosis","volume":"25","author":"C. M. A. Chinese Society of Gastroenterology","year":"2024","journal-title":"J. Dig. Dis."},{"issue":"Suppl","key":"10.1016\/j.intimp.2026.116566_bb0015","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.3350\/cmh.2024.0837","article-title":"Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B","volume":"31","author":"Zhang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.intimp.2026.116566_bb0020","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: keystones in liver inflammatory diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116566_bb0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/14728222.2023.2285763","article-title":"Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases","volume":"27","author":"Udomsinprasert","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2026.116566_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fimmu.2018.00161","article-title":"A prominent role of Interleukin-18 in acetaminophen-induced liver injury advocates its blockage for therapy of hepatic Necroinflammation","volume":"9","author":"Bachmann","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-017-0406-2","article-title":"Analyses of caspase-1-regulated transcriptomes in various tissues lead to identification of novel IL-1beta-, IL-18- and sirtuin-1-independent pathways","volume":"10","author":"Li","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0040","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.intimp.2026.116566_bb0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41423-025-01358-8","article-title":"IL-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109773","article-title":"IL-36 family cytokines in protective versus destructive inflammation","volume":"75","author":"Han","year":"2020","journal-title":"Cell. Signal."},{"issue":"32","key":"10.1016\/j.intimp.2026.116566_bb0055","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1074\/jbc.M116.723064","article-title":"Structural and functional attributes of the Interleukin-36 receptor","volume":"291","author":"Yi","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.intimp.2026.116566_bb0060","doi-asserted-by":"crossref","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","article-title":"A cytokine network involving IL-36gamma, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2026.116566_bb0065","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1080\/09546634.2022.2089335","article-title":"Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors","volume":"33","author":"Macaes","year":"2022","journal-title":"J. Dermatolog. Treat."},{"issue":"7","key":"10.1016\/j.intimp.2026.116566_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070908","article-title":"New and emerging treatments for generalized pustular psoriasis: focus on IL-36 receptor inhibitors","volume":"16","author":"Vilaca","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.intimp.2026.116566_bb0075","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jaci.2025.01.046","article-title":"IL-36-driven pustulosis: transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)","volume":"155","author":"Benezeder","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116566_bb0080","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i9.109429","article-title":"Interleukin-36 subfamily cytokines in liver diseases","volume":"17","author":"Xiong","year":"2025","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116566_bb0090","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1042\/CS20190654","article-title":"The immune niche of the liver","volume":"135","author":"Cheng","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0095","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-018-03362-1","article-title":"Redefining the ancestral origins of the interleukin-1 superfamily","volume":"9","author":"Rivers-Auty","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2026.116566_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1471-4906(01)02034-8","article-title":"Annotating genes with potential roles in the immune system: six new members of the IL-1 family","volume":"22","author":"Dunn","year":"2001","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4049\/jimmunol.1400538","article-title":"Molecular determinants of agonist and antagonist signaling through the IL-36 receptor","volume":"193","author":"Gunther","year":"2014","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116566_bb0110","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/febs.14075","article-title":"Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines","volume":"284","author":"Clancy","year":"2017","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41419-018-0385-4","article-title":"Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases","volume":"9","author":"Sullivan","year":"2018","journal-title":"Cell Death Dis."},{"issue":"49","key":"10.1016\/j.intimp.2026.116566_bb0120","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2026.116566_bb0125","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116566_bb0130","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.201242711","article-title":"The IL-36 receptor pathway regulates aspergillus fumigatus-induced Th1 and Th17 responses","volume":"43","author":"Gresnigt","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116566_bb0140","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/imr.12610","article-title":"Regulation and function of interleukin-36 cytokines","volume":"281","author":"Bassoy","year":"2018","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116566_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2016.05.023","article-title":"IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose-dependently activated via IL-36beta and induces CD4+ lymphocyte proliferation","volume":"85","author":"Penha","year":"2016","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1074\/jbc.M117.805739","article-title":"Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation","volume":"293","author":"Zhou","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116566_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2018.00080","article-title":"RNA-Seq analysis of IL-1B and IL-36 responses in epidermal keratinocytes identifies a shared MyD88-dependent gene signature","volume":"9","author":"Swindell","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0175","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00082.2019","article-title":"Hepatic MyD88 regulates liver inflammation by altering synthesis of oxysterols","volume":"317","author":"Lefort","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.116566_bb0185","first-page":"69","article-title":"Interleukin(IL)-36alpha and IL-36gamma induce Proinflammatory mediators from human colonic subepithelial Myofibroblasts","volume":"2","author":"Kanda","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"issue":"105","key":"10.1016\/j.intimp.2026.116566_bb0190","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"issue":"40","key":"10.1016\/j.intimp.2026.116566_bb0195","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1073\/pnas.1801377115","article-title":"IkappaBzeta is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes","volume":"115","author":"Muller","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0200","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.1900169","article-title":"IL-36gamma promotes killing of mycobacterium tuberculosis by macrophages via WNT5A-induced noncanonical WNT signaling","volume":"203","author":"Gao","year":"2019","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116566_bb0205","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.7150\/ijms.20809","article-title":"IL-36gamma inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116566_bb0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/15353702221147563","article-title":"The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets","volume":"248","author":"Luo","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"Pt 2","key":"10.1016\/j.intimp.2026.116566_bb0215","article-title":"Immunologic role of macrophages in sepsis-induced acute liver injury","volume":"143","author":"Xu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0042-1755274","article-title":"Management of Acute Liver Failure: update 2022","volume":"42","author":"Tujios","year":"2022","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0225","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.2100481","article-title":"The protective role of IL-36\/IL-36R signal in con A-induced acute hepatitis","volume":"208","author":"Wang","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0230","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1038\/srep08521","article-title":"Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury","volume":"5","author":"Scheiermann","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116566_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115112","article-title":"TLR3-mediated NET formation and macrophage activation in acute liver failure: targeting IL-36 signaling to attenuate inflammatory drivers","volume":"161","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116566_bb0240","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.4049\/jimmunol.1600700","article-title":"IL-36-induced toxicity in neonatal mice involves TNF-alpha production by liver myeloid cells","volume":"197","author":"Palomo","year":"2016","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2026.116566_bb0245","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1111\/bph.15858","article-title":"Modulation of interleukin-36 based inflammatory feedback loop through the hepatocyte-derived IL-36R-P2X7R axis improves steatosis in alcoholic steatohepatitis","volume":"179","author":"Shang","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116566_bb0250","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1681\/ASN.2016080840","article-title":"IL-36 signaling facilitates activation of the NLRP3 Inflammasome and IL-23\/IL-17 Axis in renal inflammation and fibrosis","volume":"28","author":"Chi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2026.116566_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.157091","article-title":"IL-36gamma signalling promotes a proinflammatory macrophage state that is associated with reduced lipid uptake","volume":"198","author":"Sieh","year":"2026","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0260","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imm.13310","article-title":"IL-36 cytokines and gut immunity","volume":"163","author":"Ngo","year":"2021","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0270","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i4.105660","article-title":"Correlation between the interleukin-36 subfamily and gut microbiota in patients with liver cirrhosis: implications for gut-liver axis imbalance","volume":"17","author":"Pan","year":"2025","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.intimp.2026.116566_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832185","article-title":"Increased levels of Interleukin-36 in obesity and type 2 diabetes fuel adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages","volume":"13","author":"Fruhbeck","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116566_bb0280","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/1871530322666220113142533","article-title":"The emerging roles of IL-36, IL-37, and IL-38 in diabetes mellitus and its complications","volume":"22","author":"Huang","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0285","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.intimp.2026.116566_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155663","article-title":"Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD","volume":"147","author":"Fernandez-Saez","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2026.116566_bb0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.micpath.2017.11.023","article-title":"Elevated production of IL-36alpha in chronic hepatitis B virus-infected patients correlates with viral load","volume":"113","author":"Gong","year":"2017","journal-title":"Microb. Pathog."},{"issue":"6","key":"10.1016\/j.intimp.2026.116566_bb0300","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2017.07.028","article-title":"Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56(bright) NK cells","volume":"67","author":"Mele","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2026.116566_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552606","article-title":"High expression of IL-36gamma in influenza patients regulates interferon signaling pathway and causes programmed cell death during influenza virus infection","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0310","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1038\/s41467-019-12318-y","article-title":"IL-36 promotes anti-viral immunity by boosting sensitivity to IFN-alpha\/beta in IRF1 dependent and independent manners","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0315","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/mi.2016.107","article-title":"IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia","volume":"10","author":"Aoyagi","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194733","article-title":"Interleukin-36gamma is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice","volume":"14","author":"Anzaghe","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1163198","article-title":"Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis","volume":"14","author":"Koop","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0330","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","article-title":"Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation","volume":"156","author":"Scheibe","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2026.116566_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155921","article-title":"Interleukin-36alpha is elevated in diffuse systemic sclerosis and may potentiate fibrosis","volume":"156","author":"O'Reilly","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116566_bb0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2022.02.015","article-title":"Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases","volume":"530","author":"Zhang","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.intimp.2026.116566_bb0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0350","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.154992","article-title":"IL-36alpha contributes to enhanced T helper 17 type responses in allergic rhinitis","volume":"128","author":"Qin","year":"2020","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0360","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116566_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.107061","article-title":"Elevated ascitic interleukin-36 receptor antagonist mediates CD8(+)T cell exhaustion in vitro in liver cirrhotic patients with spontaneous bacterial peritonitis","volume":"276","author":"Yang","year":"2025","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2026.116566_bb0370","article-title":"The role of IL-36 and 37 in hepatocellular carcinoma","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116566_bb0375","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00262-013-1471-1","article-title":"Decreased expression of interleukin-36alpha correlates with poor prognosis in hepatocellular carcinoma","volume":"62","author":"Pan","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2026.116566_bb0380","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2147\/CMAR.S407123","article-title":"The pro-tumor biological function of IL-36alpha plays an important role in the tumor microenvironment of HCC","volume":"15","author":"Song","year":"2023","journal-title":"Cancer Manag. Res."},{"issue":"21","key":"10.1016\/j.intimp.2026.116566_bb0385","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.7150\/jca.47106","article-title":"IL36 indicating good prognosis in human hepatocellular carcinoma","volume":"11","author":"Hu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2026.116566_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156397","article-title":"Prognostic value of interleukin-36s in cancers: A systematic review and meta-analysis","volume":"172","author":"Zhang","year":"2023","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.intimp.2026.116566_bb0395","article-title":"Luteolin alleviates AflatoxinB(1)-induced apoptosis and oxidative stress in the liver of mice through activation of Nrf2 signaling pathway","volume":"10","author":"Rajput","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116566_bb0400","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"I. Effisayil 1 trial, trial of Spesolimab for generalized pustular psoriasis","volume":"26","author":"Bachelez","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0405","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaad.2023.02.040","article-title":"Rapid and sustained improvements in generalized pustular psoriasis physician global assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study","volume":"89","author":"Elewski","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0410","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1346-8138.16609","article-title":"Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: results from the randomized, double-blind, placebo-controlled Effisayil 1 study","volume":"50","author":"Morita","year":"2023","journal-title":"J. Dermatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116566_bb0415","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s13555-023-01002-1","article-title":"Spesolimab efficacy and safety in patients with moderate-to-severe palmoplantar pustulosis: a multicentre, double-blind, randomised, placebo-controlled, phase IIb, dose-finding study","volume":"13","author":"Burden","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"issue":"10412","key":"10.1016\/j.intimp.2026.116566_bb0420","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","article-title":"Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial","volume":"402","author":"Morita","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.intimp.2026.116566_bb0425","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/1346-8138.17449","article-title":"Spesolimab, the first-in-class anti-IL-36R antibody: from bench to clinic","volume":"51","author":"Morita","year":"2024","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116566_bb0430","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bjd\/ljae144","article-title":"Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial","volume":"191","author":"Alavi","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116566_bb0435","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/ard-2023-225158","article-title":"Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis","volume":"83","author":"Gronberg","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2026.116566_bb0440","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00262-021-02860-4","article-title":"IL-36gamma-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity","volume":"70","author":"Yang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2026.116566_bb0445","article-title":"Designed DNA-encoded IL-36 gamma acts as a potent molecular adjuvant enhancing Zika synthetic DNA vaccine-induced immunity and protection in a lethal challenge model","volume":"7","author":"Louis","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116566_bb0450","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1038\/s41598-017-05363-4","article-title":"Interleukin-36beta provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses","volume":"7","author":"Milora","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116566_bb0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2018.07.034","article-title":"IL-36gamma induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis","volume":"111","author":"Gardner","year":"2018","journal-title":"Cytokine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600411X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600411X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:32:51Z","timestamp":1774686771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600411X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":91,"alternative-id":["S156757692600411X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116566","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116566"}}